Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process.
about
Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicityRole of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetusRegulation of iNOS gene transcription by IL-1β and IFN-γ requires a coactivator exchange mechanism.Protective role of nitric oxide in Staphylococcus aureus infection in mice.Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaBNovel experimental strategies to prevent the development of type 1 diabetes mellitus.Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.Stimulus-induced S-nitrosylation of Syntaxin 4 impacts insulin granule exocytosisHyperuricemia causes pancreatic β-cell death and dysfunction through NF-κB signaling pathway.Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes.Unraveling the pathogenesis of type 1 diabetes with proteomics: present and future directions.Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase.Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase.Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice.Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1).Do β-cells generate peroxynitrite in response to cytokine treatment?NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.Targeting advanced glycation with pharmaceutical agents: where are we now?Host systemic and local nitric oxide levels do not correlate with rejection of pig proislet xenografts in mice.Nitric oxide and pancreatic beta-cell destruction in insulin dependent diabetes mellitus: don't take NO for an answer.Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage.Autotoxicity of nitric oxide in airway disease.Fusidic acid and insulin-dependent diabetes mellitus.β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell Destruction.Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion.TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii.Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.Effects of antioxidants coenzyme Q10 and lipoic acid on interleukin-1 beta-mediated inhibition of glucose-stimulated insulin release from cultured mouse pancreatic islets.The changes of the thyroid function and serum testosterone levels after long-term L-NAME treatment in male rats.Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
P2860
Q28379134-1B2BE746-8192-4190-AEAC-F23CCB2CDCD7Q28379295-D733A0A3-C40D-4150-B334-98AB8B1911F7Q33669239-7C366A44-1722-434A-B010-A983DC9244B8Q33751428-6B2F43D1-63F6-4AA1-8D67-7B9722772BE5Q33867520-8AB18AF5-C00C-461A-ABDB-82397FDD0038Q34091863-47EDFC72-2785-4F6D-B635-B7C70E6815D0Q34731064-99BFD496-F1BD-436E-B760-F3629695BF44Q34963637-3206386C-44A4-4A32-B5E2-5847366FB54AQ35036279-B3EAB8A6-607E-4B43-AC9B-3EE2A4F840E6Q35310273-02FDA5D1-8323-4E9B-9B4D-7D26B8D4163DQ35824735-FDA224BA-F242-4309-BDE2-34F460A6AAA9Q36033860-FA9138A7-BC7E-4F56-9474-081A95E7C722Q36364285-1D2ECF09-700F-4944-BBE5-3CB1A460314CQ36364369-B46DEC66-2883-4399-B723-2E8E17E2BDD6Q36447295-19148E33-BDCD-4A8D-A1C6-80989C598E86Q36561742-319C50BF-D4E7-41D5-B9CF-40D9759899E4Q37405043-4EFBB854-94F8-4C98-9263-0A91990D3DB8Q37575397-F254AF5E-C7AA-4950-A95B-9378E0724ACAQ37606940-98189491-46AE-4727-B95B-5141FBEE45C8Q38890348-4B86CA1F-BCAE-4553-ACCA-E02B99C5DF2EQ40583343-25FB1764-5581-4F93-B883-E379808C92F1Q40594291-97F9F7F1-C561-44DF-AD81-1DE8D8F3B2E1Q41116781-B49E38D3-9DA6-4C8A-9259-8AC59C825BF1Q41171890-1D7451F5-496B-4B11-B792-A14B4B9DACA1Q41340891-F8AF8A7C-1EC3-444F-B8F8-2FCB33818673Q42943802-BF32CB3F-5E24-486B-BDA8-1EE2C7BDA70CQ44449615-AD29DFB0-B825-42FA-ABE7-0C58D48313FAQ44636873-A8F23F3A-3312-4BF5-BA97-00B5280A7B4BQ46284091-502D40A1-95CC-4FA7-9416-6030D30D165BQ46416312-CCEAA1D7-6E34-49B6-A63B-C477FAF9C40EQ48451175-4A7DCC43-79F1-4547-9449-4D090FC03FE0Q55195388-0DD72506-5A9B-4F49-B4AE-7F6E06C72951
P2860
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Nitric oxide production in isl ...... mmunological diabetic process.
@ast
Nitric oxide production in isl ...... mmunological diabetic process.
@en
type
label
Nitric oxide production in isl ...... mmunological diabetic process.
@ast
Nitric oxide production in isl ...... mmunological diabetic process.
@en
prefLabel
Nitric oxide production in isl ...... mmunological diabetic process.
@ast
Nitric oxide production in isl ...... mmunological diabetic process.
@en
P2093
P2860
P356
P1476
Nitric oxide production in isl ...... immunological diabetic process
@en
P2093
E R Unanue
J A Corbett
K Frederick
M L McDaniel
O Kanagawa
P2860
P304
P356
10.1073/PNAS.90.19.8992
P407
P50
P577
1993-10-01T00:00:00Z